Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sae Han to distribute erectile dysfunction treatment in Korea

April 5, 1996

Lilly claims glucagon-like peptide fragments

April 5, 1996

Jones Medical will market thiamazole in U.S.

April 5, 1996

RSR13 enhances oxygen delivery to tissues

April 5, 1996

Agennix collaboration with Gist-Brocades for lactoferrin

April 5, 1996

Progenitor patent on leptin receptor published

April 5, 1996

Warner-Lambert discloses ACAT inhibitors

April 5, 1996

BMS claims beta3 agonists in patent literature

April 5, 1996

ACAT inhibitors claimed by DuPont Merck

April 5, 1996

Pierre Fabre reports hypocholesterolemic organosilanes

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 17, 2025.
Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM
BioWorld
The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as...
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.